PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies.
about
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationA decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectivesConcurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer.The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer.Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas.Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.Mutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma.Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci.Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture.Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling.Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression.Rare frequency of gene variation and survival analysis in thymic epithelial tumors.Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells.Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors.
P2860
Q26765060-04824BBF-B9D1-4D3C-8AEE-2E4514036258Q26797297-9CC370D2-4BFE-4757-9195-A3527F9FC81DQ33648747-2F944C9E-AAE6-4557-A2A9-9F1FC69F86F4Q36316643-9B5EC154-3AA1-4B3D-B3D6-06030D47AF9BQ36598758-4A29009C-1F10-483A-AB9A-3890A9692B1CQ36772120-C3594150-3143-469B-B1F5-A389270F7185Q37373041-A4D3596D-B2DB-476D-8B2C-9D1DF1F4D35DQ37633874-7CF8409E-9499-4B90-9E48-6F8CD78C48F3Q37716406-7DD2AAFF-CCFC-41CB-826F-A490286049FBQ38824661-BE68EECA-D816-44DD-9901-C918EBAF3B59Q39002233-0E89AC38-B6BD-4611-84EF-D3F364E94FFBQ41518202-CB921AB0-D3BA-43E2-9968-3E0EF28415E9Q47158976-1EC038AB-9489-4B34-9E78-03DC2F9CFBB3Q53209584-E42439EF-6FF1-4424-BAF9-12251D266981
P2860
PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
PIK3CA mutations in non-small ...... cidence of prior malignancies.
@ast
PIK3CA mutations in non-small ...... cidence of prior malignancies.
@en
type
label
PIK3CA mutations in non-small ...... cidence of prior malignancies.
@ast
PIK3CA mutations in non-small ...... cidence of prior malignancies.
@en
prefLabel
PIK3CA mutations in non-small ...... cidence of prior malignancies.
@ast
PIK3CA mutations in non-small ...... cidence of prior malignancies.
@en
P2093
P2860
P356
P1433
P1476
PIK3CA mutations in non-small ...... cidence of prior malignancies.
@en
P2093
Britta Kaminsky
Carina Heydt
Carolin Becker
Erich Stoelben
Frank Ueckeroth
Jana Fassunke
Jens Panse
Jürgen Wolf
Karin Töpelt
Katharina König
P2860
P304
P356
10.18632/ONCOTARGET.2834
P407
P577
2015-01-01T00:00:00Z